All News Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-07-07 EDT			5-day change	1st Jan Change
31 ^TWD	+3.33%		+1.31%	+22.53%

05-14	Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	04-15	BU
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	04-15	CI
Applied BioCode Announces Retirement of CEO Chris Bernard	03-21	BU
Applied BioCode Announces CEO Changes	03-21	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer	23-09-28	BU
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer	23-09-28	CI
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer	23-09-22	CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-27	CI
Applied BioCode Corporation Announces the Change of Representative of Institutional Director	23-06-14	CI
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use	23-06-12	BU
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	23-06-12	CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Applied BioCode Announces Distribution Agreement with Medline Industries	23-05-08	BU
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	23-05-08	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer	23-03-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Applied BioCode Corporation

Equities

6598

KYG0488D1051

All News

Filters